WASHINGTON — The HIV and AIDS epidemic could become uncontained if current funding trends continue, warned one of the founding architects of the United States President’s Emergency Plan for AIDS Relief.
“We are, in my view, at highest risk ever of losing control of the epidemic since all of this began,” Dr. Mark Dybul said at an event at the Center for Strategic and International Studies in Washington, D.C., on April 18. “Then, what do we do differently? How do we invest differently?”
Dybul’s words about the stark future of the HIV and AIDS epidemic came as the Institute for Health Metrics and Evaluation at the University of Washington released a report about global health financing, which found that development assistance for HIV and AIDS has decreased annually by 5.4 percent since 2012.
The study tracks health spending in 188 countries and logs it by disease, including HIV and AIDS, which has received the largest share of global health spending since 2000, at 26.8 percent. According to the report, the annualized increase of 11.9 percent in funding for HIV and AIDS has “mitigated a major global health crisis.” While money also comes from domestic governments, most low- and middle-income countries rely on development assistance for health to fund their response.
But not enough is being given globally, Dybul said.
“The reality is, and I think what’s behind the numbers, is that no one besides the United States has a bilateral program on HIV anymore,” said Dybul, who helped formulate PEPFAR and then served as its chief medical officer, acting director, and U.S. global AIDS coordinator. He is now the co-director of the Center for Global Health and Quality at Georgetown University.
HIV treatment: Strategies to reach the next 10 million patients
The world is on track to get 30 million HIV patients on treatment by 2030. But the last push will be the hardest, extending care to the most marginalized populations. Here are some of the innovations and strategies that scientists and practitioners are considering to tackle the challenge.
“There is a larger dependency on basically two organizations, bilateral PEPFAR, and the Global Fund [to Fight AIDS, Tuberculosis and Malaria.] That’s all pretty much all that’s left from external financing perspective. The U.S. leadership in that is huge, and if the U.S. doesn’t maintain its leadership position, the rest of the countries are just looking for an excuse to get out of HIV. They don’t want to be in it,” Dybul said.
In 1995, 18 million people were living with HIV and AIDS and 3 million more were being diagnosed each year, according to the study. The epidemic peaked in 2005, when almost 2 million people were dying from the disease each year and 31 million were living with it. The global campaign against HIV and AIDS led to a 23 percent reduction in cases since 2005, and the death rate decreased by 47 percent between 2005 and 2015.
The Financing Global Health 2017 report includes the most comprehensive analysis ever conducted of global HIV and AIDS spending. This is vital information if the world hopes to stop a reversal of the success it has seen in stemming the epidemic, experts say.
“The estimates by country for the first time of government spending on HIV, which has been something that a lot of us working in the field have needed and wanted ... it’s in this report. They’re estimates, but they’re really the only comprehensive source of that that I’ve ever seen,” said Jennifer Kates, vice president and director of global health and HIV policy at the Kaiser Family Foundation. “This is filling a major gap in our toolkit that we need for policy and program.”
“If the U.S. doesn’t maintain its leadership position, the rest of the countries are just looking for an excuse to get out of HIV. They don’t want to be in it.”
—Dr. Mark Dybul, co-director of the Center for Global Health and QualityOne of the causes for concern experts have identified is the disengagement young people have from the issue of HIV and AIDS, and the fact that they are not accessing services at a rate matching the growth of their share of the population. Dybul said that if the infection rate were to stay where it is today, as the 18 to 25-year old population doubles, the infection rate will double.
“Young people aren’t accessing services. And why we think all of a sudden they’re going to use self tests is beyond my comprehension. Every study shows that young people in Africa don’t think about HIV anymore. They think about other things,” Dybul said. “How we then fit HIV into a bigger picture — which is health, and economic growth and development, and particularly how we deal with young people — that could help us not necessarily get more money but have much more impact with the resources that we’re using.”
Total global health spending is not expected to decrease in the coming years, with the study predicting global health spending will reach $15.4 trillion in 2030. Tracking how money is spent is key, according to the report, to inform policy, evaluate results, and identify areas where more investment could improve health outcomes.
“This is just not how you combat an infectious disease. Infectious diseases spread,” Kates said. “There’s empirical evidence of what happens when you scale back. It’s very predictable, and so we’re not approaching this challenge in a way that works.”
About the author
Teresa Welshtmawelsh
Teresa Welsh is a Senior Reporter at Devex. She has reported from more than 10 countries and is currently based in Washington, D.C. Her coverage focuses on Latin America; U.S. foreign assistance policy; fragile states; food systems and nutrition; and refugees and migration. Prior to joining Devex, Teresa worked at McClatchy's Washington Bureau and covered foreign affairs for U.S. News and World Report. She was a reporter in Colombia, where she previously lived teaching English. Teresa earned bachelor of arts degrees in journalism and Latin American studies from the University of Wisconsin.
